Theravance Biopharma, Inc.TBPHNASDAQ
Loading
Cash generated from core business operations
Latest
$243.70M
↑ 323% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
$-109.12M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $243.70M | +2212.7% |
| 2024 | $-11.54M | +57.3% |
| 2023 | $-27.00M | +85.6% |
| 2022 | $-186.99M | +10.0% |
| 2021 | $-207.86M | +17.0% |
| 2020 | $-250.40M | -5.1% |
| 2019 | $-238.20M | -111.0% |
| 2018 | $-112.87M | +43.9% |
| 2017 | $-201.05M | -103.1% |
| 2016 | $-98.99M | - |